Silence Therapeutics Announces Issuance of Patent Covering Methods for Enhancing Silencing Activity of RNAi Therapeutics
Patent Covers Structural Modifications Associated with Innovative Zamore 'Design Rules'
14-Jun-2010 -
Silence Therapeutics plc announced the issuance of United States patent 7,732,593, titled Methods and Compositions For Controlling Efficacy of RNA Silencing, by the United States Patent and Trademark Office (USPTO). The issued patent, which is based on the seminal research of Phillip D. Zamore, ...
Bio-Medical Science
biochemistry
gene expression
+3